Fish oil-based lipid emulsion decrease inflammation and bronchopulmonary dysplasia in extremely premature infants

Completed

• Conditions: Insufficent docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) in premature babies; Neonatal Diseases

• Registration Number: ISRCTN11427103
• Lead Sponsor: Changhua Christian Hospital

Brief Summary

2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29941233

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2014-02-28
• Study Start: 2015-09-15
• Last Update Posted: 16 July 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

PVLBW infants who weighed below 1250 gm and gestational age below 32 weeks

Exclusion Criteria

1. Chromosomal disorders or lethal congenital abnormalities
2. Congenital cyanotic heart disease
3. Anatomic obstructive gastrointestinal pathologies, such as intestinal malrotation with or without volvulus, stenosis, or atresia, gastroschisis, omphalocele and Hirschsprung’s disease
4. Confirmed or family history of hereditary metabolic disorder

Study & Design

• Study Type: Interventional
• Study Design: Not specified